Assessing heart tissue damage in patients with heart aneurysms after a heart attack

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate myocardial fibrosis in patients with ventricular aneurysm following an acute myocardial infarction using 18F-FAPI PET/CT imaging. Participants will undergo a PET/CT scan during their hospital stay, along with serial echocardiography and follow-up assessments over one year. The study will analyze the relationship between the imaging results and clinical markers of disease progression, providing insights into the nature of myocardial fibrosis in these patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged 18-75 years old
* Diagnosed with STEMI or NSTEMI (ACC/AHA guidelines)
* Half male and half female
* Undergo CAG and PCI treatment;
* Receive either echocardiography or CMR to identify a ventricular aneurysm;
* Written informed consent

Exclusion Criteria:

* Patients under the age of 18 years old;
* Patients who are pregnant/breastfeeding;
* Patients who has a previous history of allergy to radio tracers.

Where it's running

• Renji Hospital
  Shanghai, China Recruiting

Study contacts

• Study coordinator: ZHIGUO ZOU, MD, PhD
• Email: zouzhiguo@renji.com
• Phone: 13524596108

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating a noninvasive tissue sensor to detect cardiogenic shock earlier in heart patients

  This pilot, noninvasive study tests whether the NIRSense wearable can help detect deterioration in adults with cardiogenic shock risk due to heart attack or heart failure.

  Recruiting NIRSense Inc. · Weston, Florida · NCT07825363

• Myocardial Perfusion and Tissue Characterization with Photon-Counting CT in TAVI Patients

  This study tests whether photon-counting CT can measure heart blood flow and tissue properties as well as MRI in patients planning a TAVI procedure.

  Recruiting Karolinska University Hospital · Huddinge, Stockholm County · NCT07799363

• Adenosine given before primary PCI to reduce no-reflow in STEMI patients.

  See if giving intracoronary adenosine before primary PCI lowers the chance of slow flow/no-reflow in adults with STEMI.

  Recruiting at 2 sites Phase 4 National Institute of Cardiovascular Diseases, Pakistan · Karachi, Sindh and 1 other locations · NCT07536802

• Subclinical depression in people after a first heart attack (SUBDIMA25)

  This project will test how common mild depressive symptoms are in adults hospitalized for a first heart attack and whether those symptoms relate to biomarkers, heart function, and recovery over the next year.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma, Italia · NCT07492537

• Long-term follow-up after Hearticellgram-AMI treatment

  We will follow people who got one dose of Hearticellgram-AMI after a heart attack for up to 60 months to see if the treatment stays safe.

  Recruiting Pharmicell Co., Ltd. · Seoul, Gangnam · NCT07400458

• Gallium-68 FAPI PET/CT to find cardiac fibrosis in heart failure

  This test will use a Gallium-68 FAPI PET/CT scan to see if it can detect active heart muscle fibrosis in adults with heart failure.

  Recruiting University of Coimbra · Coimbra, Coimbra District · NCT07296081

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.